Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01977144 · ClinicalTrials.gov registry record · NA

Screening of Low Responders for Aneuploidy to Improve Reproductive Efficiency

A NA study, sponsored by Reproductive Medicine Associates of New Jersey.

Completed
Registry status
NA
Development phase
206
Enrollment target

NCT01977144 is a NA study that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 206 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01977144, a NA study, has completed, sponsored by Reproductive Medicine Associates of New Jersey.

COMPLETED
Registry status
NA
Development phase
206 participants
Enrollment target

Study Summary

The purpose of this study is to assess the impact of Comprehensive Chromosome Screening(CCS) on patients with low ovarian reserve in an effort to improve success during in vitro fertilization and decrease the time to successful pregnancy.

Interventions

  • OTHER Comprehensive Chromosomal Screening

Trial Details

FieldValue
Enrollment Target 206 participants
Start Date 2013-09-25
Est. Completion 2020-01-01
Phase NA

What the Registry Record Tells You About NCT01977144

The ClinicalTrials.gov registry entry for NCT01977144 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Reproductive Medicine Associates of New Jersey, which has 51 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Comprehensive Chromosomal Screening is the first listed.

NCT01977144 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01977144 about?

NCT01977144 is a clinical study titled "Screening of Low Responders for Aneuploidy to Improve Reproductive Efficiency". The purpose of this study is to assess the impact of Comprehensive Chromosome Screening(CCS) on patients with low ovarian reserve in an effort to improve success during in vitro fertilization and decrease the time to successful pregnancy.

What is the current status of trial NCT01977144?

This trial is currently completed. It is a NA study. The enrollment target is 206 participants. The study started on 2013-09-25. Estimated completion is 2020-01-01.

What interventions are being tested in trial NCT01977144?

The interventions under investigation include: Comprehensive Chromosomal Screening (OTHER).

Who is sponsoring clinical trial NCT01977144?

This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.